Aksh Optifibre share news, announcements and annual reports
NSE: AKSHOPTFBRBSE: 532351Telecom - Equipment & AccessoriesSmall Cap
Aksh Optifibre Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2000
Last close ₹6.92down ₹0.25 (3.49%)BSE ₹6.97
Share price at the NSE close on 30 Oct 2026. Previous close ₹7.17.
30 Oct: open ₹7.20, high ₹7.20, low ₹6.83
52-week range of traded prices to 30 Oct 2026
₹3.82Low, 30 Mar 2026₹9.01High, 10 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹113 Cr2,957th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Assets held for saleon the latest balance sheet
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them.
- Assets held for saleon the latest balance sheet
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Assets held for saleon the latest balance sheet
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,86,015
Aksh Optifibre shareholding disclosures
118 filed, newest first. Page 2 of 3.
Nov 2013
Sep 2013
Aug 2013
Jul 2013
Apr 2013
Jun 2012
Apr 2012
Mar 2012
Feb 2012
Jan 2012
Dec 2011
8 Dec · Disclosure
Nov 2011
Jul 2011
Mar 2010
23 Mar · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 539,899 equity shares of the Company between March 15, 2010 to March 18, 2010 (both days inclusive). Therefore his shareholding after the above transaction is 4728025 equity shares aggregating to 7.80% of the total issued, subscribed and paid up equity share capital of Company.
Feb 2010
3 Feb · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 109,954 equity shares of the Company between January 27, 2010 to January 29, 2010 (both days inclusive). Therefore his shareholding after the above transaction is 52,67,924 equity shares aggregating to 8.835% of the total issued, subscribed and paid up equity share capital of Company.
Jan 2010
7 Jan · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 714,165 equity shares of the Company between December 29, 2009 to January 05, 2010 ( both days inclusive). Therefore, his shareholding after the above transaction is 5377878 equity shares aggregating to 9.12% of the total issued, subscribed and paid-up equity share capital of Company.
Dec 2009
29 Dec · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 248262 equity shares of the Company between December 07, 2009 to December 24, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 6092043 equity shares aggregating to 10.33% of the total issued, subscribed and paid-up equity share capital of Company.7 Dec · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 222766 equity shares of the Company between November 30, 2009 to December 04, 2009 ( both days inclusive). Therefore, his shareholding after the above transaction is 6340305 equity shares aggregating to 10.75% of the total issued, subscribed and paid-up equity share capital of Company.2 Dec · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 190723 equity shares of the Company between November 23, 2009 to November 26, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 6563071 equity shares aggregating to 11.13% of the total issued, subscribed and paid-up equity share capital of the Company.
Nov 2009
23 Nov · Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992 as amended, this is to inform you that Dr. Kailash S. Choudhari, Managing Director of the Company, has sold 262,640 equity shares of the Company between 16th November, 2009 to 18th November 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 6753794 equity shares aggregating to 11.45% of the total issued, subscribed and paid-up equity share capital of Company.